TARGET HEALTHCARE REIT PLC financials
TARGET HEALTHCARE REIT PLC
213800RXPY9WULUSBC04 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | £72.9M | £69.6M |
| Other income | £11.0K | £9.0K |
| Net finance income / (cost) | -£11.0M | -£11.6M |
| Finance costs | £11.5M | £11.7M |
| Profit before tax | £60.8M | £73.0M |
| Income tax expense | £0 | £0 |
| Profit for the year | £60.8M | £73.0M |
| Total comprehensive income | £59.4M | £69.7M |
| Per share | ||
| Basic EPS | £0.10 | £0.12 |
| Cash flow statement | ||
| Cash generated from operations | -£9.7M | -£9.9M |
| Net cash from operating activities | £41.1M | £42.3M |
| Net cash from investing activities | -£3.2M | £3.4M |
| Net cash from financing activities | -£37.1M | -£22.2M |
| Dividends paid | £36.1M | £35.2M |
| Proceeds from borrowings | £13.0M | £52.5M |
| Repayments of borrowings | £14.0M | £39.5M |
| Balance sheet | ||
| Total assets | £986.2M | £967.4M |
| Non-current assets | £942.3M | £922.8M |
| Current assets | £43.9M | £44.6M |
| Trade & other receivables | £3.7M | £5.7M |
| Cash & equivalents | £39.6M | £38.9M |
| Total equity | £712.5M | £689.3M |
| — attributable to owners | £712.5M | £689.3M |
| Non-current liabilities | £161.1M | £250.6M |
| Long-term borrowings | £148.4M | £240.7M |
| Current liabilities | £112.6M | £27.5M |
| Short-term borrowings | £91.9M | £0 |
| Trade & other payables | £20.7M | £27.5M |
| Derived metrics | ||
| Net margin | 83.4% | 105.0% |
| Return on equity | 8.5% | 10.6% |
| Cash conversion ratio | 0.68× | 0.58× |
| Other reported items | ||
| Adjustments For Decrease Increase In Trade and Other Receivables | £1.4M | £3.1M |
| Adjustments For Finance Income Cost | -£11.5M | -£11.7M |
| Adjustments For Increase Decrease In Trade and Other Payables | £646.0K | £2.1M |
| Adjustments For Interest Income | £426.0K | £66.0K |
| Capital Reserve | £101.5M | £77.7M |
| Current Derivative Financial Assets | £572.0K | £0 |
| Dividends Recognised As Distributions To Owners Per Share | £0.06 | £0.06 |
| Gains Losses On Financial Assets Measured At Fair Value Through Other Comprehensive Income Net of Tax | -£1.4M | -£3.3M |
| Increase Decrease In Cash and Cash Equivalents | £755.0K | £23.5M |
| Interest Paid Classified As Operating Activities | £10.1M | £10.0M |
| Interest Received Classified As Operating Activities | £426.0K | £66.0K |
| Investment Property | £840.4M | £831.6M |
| Issued Capital | £6.2M | £6.2M |
| Liabilities | £273.7M | £278.1M |
| Merger Reserve | £47.8M | £47.8M |
| Net Assets Liabilities | £712.5M | £689.3M |
| Noncurrent Derivative Financial Assets | £0 | £2.8M |
| Noncurrent Payables | £12.7M | £9.9M |
| Noncurrent Receivables | £101.9M | £88.4M |
| Other Comprehensive Income | -£1.4M | -£3.3M |
| Other Expense By Nature | £3.9M | £3.1M |
| Proceeds From Sales of Investment Property | £9.8M | £44.3M |
| Purchase of Investment Property | £13.0M | £40.9M |
| Rental Income | £71.2M | £69.5M |
| Reserve of Cash Flow Hedges | £291.0K | £1.7M |
| Retained Earnings | £139.6M | £129.0M |
| Revenue From Interest | £426.0K | £66.0K |
| Share Premium | £256.6M | £256.6M |
Every line item above is a fact tagged in TARGET HEALTHCARE REIT PLC's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (GBP), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.